$ARAV - Aravive Announces Positive Initial Results from Phase 1b Portion of the Phase1b/2 Study of AVB-500 in Combination with Cabozantinib in Clear Cell Renal Carcinoma: https://finance.yahoo.com/news/aravive-announces-positive-initial-results-110000888.html
$MRIN - Best Stock of the Day: Marin Software Inc. (MRIN): https://finance.yahoo.com/news/best-stock-day-marin-software-165153628.html